ABBVIE INC. (ABBV)
Clinical trial NCT06575192 updates: 1. completion date: 2029-12-01 → 2031-02-01 2. primary completion date: 2029-12-01 → 2031-02-01 3. enrollment: 783 → 264 participants 4. allocation: NON_RANDOMIZED → NA 5. intervention model: PARALLEL → SINGLE_GROUP
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical